BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38357561)

  • 1. Evaluation of MMP-9, IL-6, TNF-α levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease.
    Akbari T; Kazemi Fard T; Fadaei R; Rostami R; Moradi N; Movahedi M; Fallah S
    J Cardiovasc Thorac Res; 2023; 15(4):223-230. PubMed ID: 38357561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of IP10 and miRNA 296-a Expression Levels in Peripheral Blood Mononuclear Cell of Coronary Artery Disease Patients and Controls.
    Kazemi Fard T; Tavakoli S; Ahmadi R; Moradi N; Fadaei R; Mohammadi A; Fallah S
    DNA Cell Biol; 2020 Sep; 39(9):1678-1684. PubMed ID: 32716219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Expression of miR-10a in Coronary Artery Disease and its Association with Pro/Anti-Inflammatory Cytokines.
    Moradi N; Fadaei R; Ahmadi R; Kazemian E; Fallah S
    Clin Lab; 2018 May; 64(5):847-854. PubMed ID: 29739060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serum MMP-9 levels and vitamin D receptor polymorphisms in the susceptibility to coronary artery disease: An association study in Iranian population.
    Moradi N; Fadaei R; Ahmadi R; Mohammad MH; Shahmohamadnejad S; Tavakoli-Yaraki M; Aghajani H; Fallah S
    Gene; 2017 Sep; 628():295-300. PubMed ID: 28739397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
    Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.
    Jönsson S; Lundberg A; Kälvegren H; Bergström I; Szymanowski A; Jonasson L
    PLoS One; 2011 Apr; 6(4):e19340. PubMed ID: 21559401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease.
    Fitzsimmons PJ; Forough R; Lawrence ME; Gantt DS; Rajab MH; Kim H; Weylie B; Spiekerman AM; Dehmer GJ
    Atherosclerosis; 2007 Sep; 194(1):196-203. PubMed ID: 16942771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between MMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presentation, Extent and Severity of Atherosclerotic Coronary Artery Disease.
    Tanindi A; Sahinarslan A; Elbeg S; Cemri M
    Open Cardiovasc Med J; 2011; 5():110-6. PubMed ID: 21772929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Arterial Hypertension Affect Plasma Levels of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Stable Coronary Artery Disease? A Preliminary Study.
    Kuliczkowski W; Banaszkiewicz M; Mysiak A; Makaś G; Bil-Lula I
    Cardiol Res Pract; 2019; 2019():6921315. PubMed ID: 31781384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of IL-37 and correlation with inflammatory cytokines and clinical outcomes in patients with coronary artery disease.
    Rafiei A; Ahmadi R; Kazemian S; Rahimzadeh-Fallah T; Mohammad-Rezaei M; Azadegan-Dehkordi F; Sanami S; Mirzaei Y; Aghaei F; Bagheri N
    J Investig Med; 2022 Dec; 70(8):1720-1727. PubMed ID: 35636779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarker panels as predictors of severity in coronary artery disease.
    Ben Braiek A; Chahed H; Dumont F; Abdelhak F; Hichem D; Gamra H; Baudin B
    J Cell Mol Med; 2021 Feb; 25(3):1518-1530. PubMed ID: 33381894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-α.
    Mohammad-Rezaei M; Ahmadi R; Rafiei A; Khaledifar A; Fattahi S; Samiei-Sefat A; Emami S; Bagheri N
    Mol Biol Rep; 2021 May; 48(5):4263-4271. PubMed ID: 34086163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-342-5p Expression Levels in Coronary Artery Disease Patients and its Association with Inflammatory Cytokines.
    Ahmadi R; Heidarian E; Fadaei R; Moradi N; Malek M; Fallah S
    Clin Lab; 2018 Apr; 64(4):603-609. PubMed ID: 29739089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-126 on mice with coronary artery disease by targeting S1PR2.
    Fan JL; Zhang L; Bo XH
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):893-904. PubMed ID: 32016996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia.
    Dogan A; Tuzun N; Turker Y; Akcay S; Kaya S; Ozaydin M
    Coron Artery Dis; 2008 Dec; 19(8):559-63. PubMed ID: 19005290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 and Tumor Necrosis Factor Show a Functional Hierarchy to Regulate the Production of Matrix Metalloproteases by Monocytes from Patients with Psoriasis.
    Springall R; Ortega-Springall MF; Guerrero-Ponce AE; Vega-Memije ME; Amezcua-Guerra LM
    J Interferon Cytokine Res; 2023 Mar; 43(3):140-146. PubMed ID: 36939813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis.
    Kremastiotis G; Handa I; Jackson C; George S; Johnson J
    Sci Rep; 2021 Nov; 11(1):23081. PubMed ID: 34848763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.